Search results
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News· 3 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna,...
Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma
MedPage Today· 4 days agoImmunotherapy may have been given too late, researchers suggested
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks via Yahoo Finance· 7 days agoRecap of the Week’s Most Important Stories Lilly’s CFO Departs: Lilly’s executive vice president and...
Chutes & Ladders—Sanofi research head Frank Nestle says au revoir
FierceBiotech· 7 days agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
Significant Benefit With Liver Transplantation in ACLF
Medscape· 1 day agoLiver transplantation improves survival in patients with acute-on-chronic liver failure (ACLF),...
European Midday Briefing: Stocks, Euro Hit by European Political Upheaval
Morningstar· 4 days agoEuropean stocks fell on Monday after European elections resulted in strong gains for right-wing Euroskeptic parties, prompting Emmanuel Macron to call a snap election in France. The main takeaways ...
Another Approach To Checkpoint Inhibitors: Targeting Receptors
Forbes· 4 days agoAn alternative to PD-1 targeting cancer therapies, PD-L1 checkpoint inhibitors boost antitumor...
A Benefit to Add-On Abemaciclib in Advanced Breast Cancer?
Medscape· 1 day agoAdding abemaciclib to an aromatase inhibitor improved overall survival in HR+/HER2− advanced breast...
Factbox-Battles over CEO pay across the globe
Investing.com· 1 day agoMusk said late on Wednesday that shareholders were voting by wide margins to approve the pay package. Musk's proposed pay package, the largest in...
BlackRock Favoring Growth Heading Into Second Half
ETF Trends via Yahoo Finance· 7 days agoThe BlackRock Target Allocation Team, which runs model portfolios followed by many advisors, turned even more bullish this week. Indeed, the current...